Cifras diana de hemoglobina en la insuficiencia renal crónica: Evidencia y guías de práctica clínica

Nefrologia

Volumn 27, Issue SUPPL.5, 2007, Pages 60-64

  López, F García ^a,c   Rotaeche, R Saracho ^b,c  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

^c Grupo de Nefrología Basada en la Evidencia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84888576609     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007; 369: 381-388.
2. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098.
3. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590.
4. Agency for Healthcare Research and Quality. Use of Epoetin for Anemia in Chronic Renal Failure. Summary, Evidence Report/Technology Assessment: Number 29. AHRQ Publication No. 00-E015, August 2001. Agency for Healthcare Research and Quality, Rockville, MD. 2001. http://www.ahrq.gov/clinic/epcsums/epcrfsum.htm, visualizado el 26 de julio de 2007
5. Strippoli GF, Manno C, Schena FP, Craig JC. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. Cochrane Database Syst Rev 2003; CD003967.
6. Strippoli GF, Craig JC, Manno C, Schena FP. Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2004; 15: 3154-3165.
7. Locatelli F, Pisoni RL, Akizawa T, Cruz JM, DeOreo PB, Lameire NH, Held PJ. Anemia management for hemodialysis patients: Kid ney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis 2004; 44: 27-33.
8. Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 2006; 17: 1181-1191.
9. Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter DJ. Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis 2004; 44: 866-876.
10. Coyne DW. Use of epoetin in chronic renal failure. JAMA 2007; 297: 1713-1716.
11. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47: S11-145.
12. Steensma DP. Erythropoiesis stimulating agents. BMJ 2007; 334: 648-649.
13. Bohlius J, Langensiepen S, Schwarzer G, Seidenfeld J, Piper M, Bennett C, Engert A. Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive metaanalysis. J Natl Cancer Inst 2005; 97: 489-498.
14. The Food and Drug Administration. FDA Public Health Advisory: Erythropoiesis-stimulating agents (ESAs). 14 marzo 2007. http://www.fda.gov/cder/drug/advisory/RHE2007.htm, visualizado el 26 de julio de 2007.
15. Drueke TB, Locatelli F, Clyne N, Eckardt KU, MacDougall IC, Tsakiris D, Burger HU, Scherhag A. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084.
16. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 2001; 37: S182-S238.
17. Steinbrook R. Haemoglobin concentrations in chronic kidney disease. Lancet 2006; 368: 2191-2193.
18. Thamer M, Zhang Y, Kaufman J, Cotter D, Dong F, Hernan MA. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA 2007; 297: 1667-1674.
19. Narins RG, Bennett WM. Patient care guidelines: problems and solutions. Clin J Am Soc Nephrol 2007; 2: 1-2.
20. Coyne DW. Influence of industry on renal guideline development. Clin J Am Soc Nephrol 2007; 2: 3-7.
21. Steinbrook R. Medicare and erythropoietin. N Engl J Med 2007; 356: 4-6.
22. Van Wyck D, Eckardt KU, Uhlig K, Rocco M, Levin A. Appraisal of evidence and control of bias in the Kidney Disease Outcomes Quality Initiative Guideline development process. Clin J Am Soc Nephrol 2007; 2: 8-10.
23. Steinbrook R. Guidance for guidelines. N Engl J Med 2007; 356: 331-333.
24. Remuzzi G, Ingelfinger JR. Correction of anemia-payoffs and problems. N Engl J Med 2006; 355: 2144-2146.
25. Amstrong D. Medical journal spikes articles on industrial ties of kidney group. The Wall Street Journal 26 diciembre 2006.
26. García-Altés A, Porta M. EPO: algo más que un problema de dosis. Polémica por la transparencia de las investigaciones sobre los riesgos de la eritropoyetina. El País 19 junio 2007.
27. Kassirer JP. Stacking the deck. Clin J Am Soc Nephrol 2007; 2: 212.
28. National Collaborating Centre for Chronic Conditions. Anaemia management in chronic kidney disease: national clinical guideline for management in adults and children. 2006. London, Royal College of Physicians.
29. Nissenson AR. Influence of industry on renal guideline development commentary: keeping our eye on the ball and improving chronic kidney disease patient outcomes. Clin J Am Soc Nephrol 2007; 2: 205-206.
30. Campbell D, Walker R, Mathew T, Craig J. Commentary on «Influence of industry on renal guideline development». Clin J Am Soc Nephrol 2007; 2: 211.
31. National Kidney Foundation. National Kidney Foundation Releases Preliminary Anemia Guideline Update. New Evidence Spurs Re-examination of 2006 Recommendations. National Kidney Foundation. 12 abril 2007. http://www.kidney.org/news/newsroom/newsitem. cfm?id=380, visualizado el 26 de julio de 2007.
32. National Kidney Foundation. NKF testifies about safe management of anemia public hearing: ensuring kidney patients receive safe and appropriate anemia management care. 26 junio 2007. http://www.kidney.org/news/newsroom/newsitem.cfm?id=399, visualizado el 26 de julio de 2007.